Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 9:13:101762.
doi: 10.1016/j.toxrep.2024.101762. eCollection 2024 Dec.

Ameliorating effect of S-Allyl cysteine (Black Garlic) on 6-OHDA mediated neurotoxicity in SH-SY5Y cell line

Affiliations

Ameliorating effect of S-Allyl cysteine (Black Garlic) on 6-OHDA mediated neurotoxicity in SH-SY5Y cell line

Yesim Yeni et al. Toxicol Rep. .

Abstract

Therapeutic approaches based on isolated compounds derived from natural products are more common in preventing diseases involving inflammation and oxidative stress at present. S-allyl cysteine (SAC) is a promising garlic-derived organosulfur compound with many positive effects in cell models and living systems. SAC has biological activity in various fields, enclosing healing in learning and memory disorders, neurotrophic effects, and antioxidant activity. In this study, we purposed to identify the neuroprotective activity of SAC toward 6-OHDA-induced cell demise in the SH-SY5Ycell line. For this purpose, 6-OHDA-induced cytotoxicity, and biochemical, and gene expression changes were evaluated in SH-SY5Y cells. SH-SY5Y cells grown in cell culture were treated with SAC 24 h before and after 6-OHDA application. Then, cell viability, antioxidant parameters, and gene expressions were measured. Finally, immunofluorescence staining analysis was performed. Our results showed that SAC increased cell viability by 144 % at 80 µg/mL with pre-incubation (2 h). It was observed that antioxidant levels were significantly increased and oxidative stress marker levels were decreased in cells exposed to 6-OHDA after pre-treatment with SAC (p<0.05). SAC supplementation also suppressed the increase in pro-inflammation levels (TNF-α/IL1/IL8) caused by 6-OHDA (p < 0.05). While 8-OHdG and Nop10 expressions were observed at a mild level in SAC pretreatment depending on the dose, 8-OHdG, and Nop10 expressions were observed at a moderate level in SAC treatment after 6-OHDA application (p<0.05). Our findings demonstrate the positive effect of pretreatment with SAC on SH-SY5Y cells injured by 6-OHDA, suggesting that SAC may be beneficial for neuroprotection in regulating oxidative stress and neuronal survival in an in vitro model of Parkinson's disease.

Keywords: Black garlic; Neuroinflammation; Neuroprotection; Oxidative stress; S-allyl cysteine; SH-SY5Y.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Metabolic activities of SH-SY5Y cells pretreated with SAC for 2 h (A) and treated with SAC for 24 h after 6-OHDA application (B). Data are expressed as the means ± SD. *p < 0.05 vs. 6-OHDA group.
Fig. 2
Fig. 2
Effects of SAC on the oxidative stress parameters (MDA, MPO, CAT, GSH, and SOD) of SH-SY5Y cells. Cells were treated with different doses of SAC two hours before exposure to 6-OHDA. Data are expressed as the means ± SD. *p <0.05 vs. 6-OHDA group.
Fig. 3
Fig. 3
Effects of SAC on IL-1, IL-8, and TNF-α expression. Cells were treated with distinct doses of SAC two hours before exposure to 6-OHDA. Data are expressed as the means ± SD. *p <0.05 vs. 6-OHDA group.
Fig. 4
Fig. 4
Cell culture, 8-OHdG (FITC) and Nop10 (Texas Red) images, IF, Bar:50 µm.

References

    1. Velmurugan B.K., Rathinasamy B., Lohanathan B.P., Thiyagarajan V., Weng C.F. Neuroprotective role of phytochemicals. Molecules. 2018;23(10):2485. - PMC - PubMed
    1. Lama A., Pirozzi C., Avagliano C., Annunziata C., Mollica M.P., Calignano A., Meli R., Raso G.M. Nutraceuticals: an integrative approach to starve Parkinson’s disease. Brain Behav. Immun. Health. 2020;2 - PMC - PubMed
    1. Simon D.K., Tanner C.M., Brundin P. Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin. Geriatr. Med. 2020;36(1):1–12. - PMC - PubMed
    1. Sergi D., Renaud J., Simola N., Martinoli M.G. Diabetes, a contemporary risk for Parkinson’s disease: epidemiological and cellular evidences. Front. Aging Neurosci. 2019;11:302. - PMC - PubMed
    1. Pagonabarraga J., Kulisevsky J., Strafella A.P., Krack P. Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol. 2015;14:518–531. - PubMed

LinkOut - more resources